How to use the speech recognition tool?

NCT03314207

XOLARIS

Natural history of the progression of X-linked retinitis pigmentosa.

Type: Observational



Status of the trial: Active, Recruiting

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2018-01-01
  • Closing Date: 2020-01-01

Criteria

Inclusion: Visual Acuity from20/200 to 20/20, Molecular confirmed mutation in RPGR

More information

Children: No

Adults: No

Funder Type: industry


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe

* indicates required

This ERN is supported by: